Group 1 - The core point of the article is the election of Jin Xi, a 26-year-old, as the chairman and general manager of Hongming Co., Ltd., making him one of the few "post-2000" chairmen in A-shares [2][6] - Jin Xi is the son of Jin Jian and Cai Tiehui, who are the controlling shareholders of Hongming Co., Ltd., holding over 60% of the company's shares [6] - Hongming Co., Ltd. specializes in providing high-quality packaging boxes, paper-plastic intelligent equipment, and complete automation solutions, with its products widely used in various packaging sectors [7] Group 2 - The company reported a net profit of -16.77 million yuan in 2023 and continued to incur losses in 2024, with a net profit of -9.77 million yuan [7][8] - Despite a 34.49% growth in overseas market business, the company faced slow recovery in downstream market demand and intense industry competition, leading to a decline in product sales prices [8] - For 2025, the company anticipates a net loss of between 12 million to 18 million yuan, attributed to low downstream investment demand and increased competition [8]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01105 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,354,256,546 | HKD | | 0.2 | HKD | | 470,851,309.2 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,354,256,546 | HKD | | 0.2 | HKD | | 470,851,309.2 | | 2. 股份分類 | 優先股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 否 | | | --- | -- ...

Core Viewpoint - Hongming Co., Ltd. is undergoing a board reshuffle as the current board's term is ending, with a focus on the transition to the next generation of leadership amid ongoing financial struggles [1][2]. Group 1: Board Reshuffle - The new board candidates include Jin Xi, Wang Peiyi, Liu Jiang, Zhong Shuidao, Zuo Yingkui, and Zhu Zhiwei, with Jin Xi and Wang Peiyi being notable as they represent the "second generation" of the founding family [2][3]. - Jin Xi, born in 2000, is the son of the company's founder and current chairman, Jin Jian, and has a strong educational background with degrees from New York University and Columbia University [2][3]. - Jin Jian and his wife, Cai Tiehui, who are the controlling shareholders holding over 60% of the company, will exit the board, marking a significant leadership change [3]. Group 2: Company Performance - Hongming Co., Ltd. has faced continuous financial difficulties since its listing on the Shenzhen Stock Exchange in December 2022, with negative net profits projected for 2023 and 2024 [2][5]. - In 2023, the company reported a net profit of -16.77 million yuan, and for 2024, the projected net profit is -9.77 million yuan, despite a 34.49% growth in overseas market business [5]. - The company has seen a decline in revenue, with a 13.93% decrease in the first three quarters of 2025, resulting in a net profit of -9.43 million yuan [6].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 星島新聞集團有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01105 | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | | 法定/註冊股本 | | | 上月底結存 | | | 2,354,256,546 | HKD | | | 0.2 HKD | | | 470,851,309.2 | | 增加 / 減少 (-) | | | | | | | HKD | | | | | 本月底結存 | | | 2,354,256,546 | HKD | | | 0.2 HKD | | | 470 ...

Core Viewpoint - The collaboration between 加科思 and AstraZeneca involves a total transaction value of $20.15 billion, with 加科思's drug JAB-23E73 being the focal point, yet the stock price of 加科思 fell significantly on the first trading day after the announcement [1][2]. Group 1: Transaction Details - 加科思 will receive an upfront payment of $100 million, with potential milestone payments of up to $1.915 billion based on development and commercialization progress, along with royalties on net sales outside of China [1]. - JAB-23E73 targets various KRAS mutations, which are present in approximately 23% of all cancer patients, and is currently undergoing Phase I clinical trials in China and the U.S. [1]. Group 2: Partnership with AstraZeneca - AstraZeneca will have exclusive rights to develop and commercialize the drug outside of China, while 加科思 will co-develop and commercialize it within China [2]. - 加科思 chose AstraZeneca due to its significant revenue from oncology, which is projected to account for 41% of its income in 2024, and its established global clinical network [2]. Group 3: Market Reaction and Stock Performance - Following the announcement, 加科思's stock dropped by 17% at one point, closing down 13.58% at HKD 7.83, with a total market capitalization of HKD 6.16 billion [2]. - Analysts noted that the $100 million upfront payment may not meet market expectations, which were around $200 million [2]. Group 4: Management's Perspective - The CEO of 加科思 stated that the upfront payment represents 5% of the total transaction value, which is considered reasonable compared to industry standards [3]. - The CEO also addressed the stock price decline, attributing it to the early-stage development of the biotech sector in Hong Kong and the shift in investor focus from long-term value to short-term gains [3].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 星島新聞集團有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01105 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,354,256,546 | HKD | | 0.2 | HKD | | 470,851,309.2 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,354,256,546 | HKD | | 0.2 | HKD | | 470,851,309.2 | | 2. ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 星島新聞集團有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01105 | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | | 法定/註冊股本 | | | 上月底結存 | | | 2,354,256,546 | HKD | | | 0.2 HKD | | | 470,851,309.2 | | 增加 / 減少 (-) | | | | | | | HKD | | | | | 本月底結存 | | | 2,354,256,546 | HKD | | | 0.2 HKD | | | 47 ...

Core Viewpoint - A new individual business, Yuxi Hongta District Xingdao Dessert Shop, has been established with a registered capital of 150,000 RMB, focusing on food service and sales [1] Company Summary - The legal representative of the newly established dessert shop is He Jun Dong [1] - The business scope includes licensed projects such as catering services and food sales, which require approval from relevant authorities before operation [1] - The general projects include online sales of pre-packaged food and retail of fresh fruits, which can be conducted independently with a business license [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 星島新聞集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 2. 股份分類 | 優先股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 0 | 說明 | | 5%累積可贖回可轉換優先股 | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,291,486,908 | HKD | | 0.1 HKD | | 129,148,690.8 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 1,291,486,908 | HKD | | 0.1 HKD | | 129,148,690.8 | 本月底法定/註冊股本總額： ...

Core Viewpoint - Hong Kong Sing Tao News Corporation Limited announced the resignation of its Executive Director and Co-CEO, Cai Jin, effective immediately, due to personal commitments [1] Group 1: Resignation Details - Cai Jin has formally submitted his resignation to the board, which is effective immediately [1] - Following his resignation, Cai Jin will also cease to serve as the authorized representative under the Hong Kong Stock Exchange Listing Rules and the Companies Ordinance [1] - Cai Jin clarified that there are no disagreements with the board and no other matters related to his resignation that need to be brought to the attention of shareholders or the Hong Kong Stock Exchange [1] Group 2: Background Information - Cai Jin joined Sing Tao News Group in June 2021 as Chief Operating Officer and was appointed Executive Director and Co-CEO in October 2021 [1] - During his tenure, he promoted business enhancement and new media reforms, launching several electronic platforms such as "Sing Tao Headlines" and achieving breakthroughs in cross-industry collaborations [1] - He also organized multiple socially impactful events [1]